Pamisel, Stock Price 22,750 Won (-3.19%)... Bulletin Board 'Bustling'

At this time, posts about Pharmicell are rapidly increasing on portals and stock communities, and today, foreigners are tentatively estimated to have net purchased 3,000 shares. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

As of 11:30 AM on the 2nd, Pharmicell's stock price is 22,750 KRW, down 3.19% from the previous day, with a trading volume of 5,170,443 shares, which is about 37.46% of the 5-day average trading volume. On May 29, Pharmicell became a market issue with the news of "strength due to special import approval of the COVID-19 treatment Remdesivir."

In addition to Pharmicell, posts by investors are also rapidly increasing for Hyein (003010), POSCO M-Tech (009520), and Doosan Infracore (042670).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.